Factor-based allocation has become increasingly popular in recent years. But how to implement it in practice still remains a puzzle for many investors. Two pitfalls which must be avoided are unintended sector biases and excessive concentration on a particular sector.
Factor-based investing has gained considerable traction over the past decade. Concepts such as ‘factor premiums’ or ‘smart beta’ have become popular buzzwords, and now appear frequently in mainstream financial media. Prominent institutional investors have also publicly embraced allocation to well-documented factors. But despite growing awareness as to the potential benefits, many still struggle with how to put such strategies into practice in their portfolios.
In the previous article in this series, which is dedicated to the major challenges investors face in factor investing, we advocated a comprehensive and balanced approach in terms of exposure to different premiums. Because factors can clash with each other and are virtually impossible to time effectively, investors must avoid any excessive or undesired exposure to individual premiums.
The same is true for geographic regions, countries and business sectors, as well as individual stock exposures. Portfolio construction processes that focus solely on factor premiums can lead to significant, unintended biases, especially in terms of sectors. In a recent whitepaper (1), researchers from the Scientific Beta/EDHEC-Risk Institute showed that portfolios targeting greater factor exposure also tend to focus heavily on a limited number of industries, and concentrate on fewer sectors overall.
For example, a strategy designed to capture the momentum premium without taking into consideration any other element, may rapidly lead to excessive concentration of the portfolio on a small number of industries that may be in vogue at the time. As a result, sector-specific developments can significantly undermine overall performance.
Concentration risk is especially important for generic factor-based strategies, particularly when they rely on the replication of popular smart beta indices (2). Many of these products do not have explicit concentration limits. The S&P 500 Low-volatility index is a good example. There are no constraints on sector weights, which can lead to huge concentrations. As a result, in December 2012, around 60% of this index was invested in only two sectors: utilities and consumer staples.
Investors take this issue very seriously. In fact, a FTSE Russell survey carried out in 2016 suggested that avoiding unintended sector biases ranked third among investor concerns regarding factor allocation.
Efficient factor strategies must integrate strict but workable concentration rules
Although the focus should remain on optimizing exposure to relevant factors, the merits of broad diversification across a varied selection of securities should not be forgotten. Robeco’s in-house research shows that adding constraints on sector weights to an unconstrained portfolio reduces concentration risk while not significantly altering returns, at least to a degree. At a certain point, however, concentration limits start to have a negative effect on performance.
As a result, there is a converse relationship between the return/risk ratio of a portfolio and concentration levels, as measured by the allowed active weight for regions, countries, sectors, size groups or single stocks. This means that an optimal level of concentration exists that must be taken into account by investors.
Efficient factor strategies should therefore not only focus on maximizing exposure to premiums, but should also prevent unintended geographic or sector biases, as well as undue concentration on some single stocks or sub-segments of the financial markets.
To ensure appropriate diversification, all of our quantitative strategies are subject to strict but workable concentration rules, that lead to a varied selection of stocks or bonds while avoiding excessive sector and country tilts.
For our Factor Investing Solutions and our Conservative Equities portfolios, for example, we apply position limits that allow an absolute deviation from the MSCI Index weight for regions, countries and sectors that does not exceed 10%. For size groups (large, mid and small caps), the maximum allowable deviation is 20%. Meanwhile, the maximum percentage that can be invested in a single stock is 2%.
ll these concentration limits are based on thorough research. They are monitored by the portfolio management team as well as Robeco’s Compliance department. They are intended to further reduce concentration risk while maintaining focus on the primary objective: achieving the best possible exposure to the targeted factor premiums.
The information contained on these pages is for marketing purposes and solely intended for Qualified Investors in accordance with the Swiss Collective Investment Schemes Act of 23 June 2006 (“CISA”) domiciled in Switzerland, Professional Clients in accordance with Annex II of the Markets in Financial Instruments Directive II (“MiFID II”) domiciled in the European Union und European Economic Area with a license to distribute / promote financial instruments in such capacity or herewith requesting respective information on products and services in their capacity as Professional Clients.
The Funds are domiciled in Luxembourg and The Netherlands. ACOLIN Fund Services AG, postal address: Affolternstrasse 56, 8050 Zürich, acts as the Swiss representative of the Fund(s). UBS Switzerland AG, Bahnhofstrasse 45, 8001 Zurich, postal address: Europastrasse 2, P.O. Box, CH-8152 Opfikon, acts as the Swiss paying agent. The prospectus, the Key Investor Information Documents (KIIDs), the articles of association, the annual and semi-annual reports of the Fund(s) may be obtained, on simple request and free of charge, at the office of the Swiss representative ACOLIN Fund Services AG. The prospectuses are also available via the website www.robeco.ch. Some funds about which information is shown on these pages may fall outside the scope of the Swiss Collective Investment Schemes Act of 26 June 2006 (“CISA”) and therefore do not (need to) have a license from or registration with the Swiss Financial Market Supervisory Authority (FINMA).
Some funds about which information is shown on this website may not be available in your domicile country. Please check the registration status in your respective domicile country. To view the RobecoSwitzerland Ltd. products that are registered/available in your country, please go to the respective Fund Selector, which can be found on this website and select your country of domicile.
Neither information nor any opinion expressed on this website constitutes a solicitation, an offer or a recommendation to buy, sell or dispose of any investment, to engage in any other transaction or to provide any investment advice or service. An investment in a Robeco Switzerland Ltd. product should only be made after reading the related legal documents such as management regulations, prospectuses, annual and semi-annual reports.